eedq has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CS; Kim, J; Lee, JH; Paik, SR; Shin, HJ | 1 |
| Lee, JH; Paik, SR; Shin, HJ | 1 |
2 other study(ies) available for eedq and Alzheimer Disease
| Article | Year |
|---|---|
Copper(II)-induced self-oligomerization of alpha-synuclein.
Topics: alpha-Synuclein; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Binding Sites; Cations; Chromatography, High Pressure Liquid; Copper; Dicyclohexylcarbodiimide; Endopeptidases; Humans; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Metalloendopeptidases; Metals; Molecular Weight; Nerve Tissue Proteins; Parkinson Disease; Peptide Fragments; Protein Binding; Quinolines; Synucleins | 1999 |
Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Topics: Alkylating Agents; alpha-Synuclein; Alzheimer Disease; Catalysis; Chlorides; Copper; Dicyclohexylcarbodiimide; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Ferric Compounds; Humans; Hydrogen Peroxide; Metals; Nerve Tissue Proteins; Oxidation-Reduction; Quinolines; Recombinant Proteins; Spectrometry, Fluorescence; Synucleins; Time Factors | 2000 |